journal article·2025-05-16Open access

Exploring Protein Corona Formation on Fucoidan-Coated Poly(isobutyl cyanoacrylate) Nanoparticles: Implications for Drug Delivery

Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares, Sinara Mônica Vitalino de Almeida, Otília Pessoa, Evandro Silva, Marcelo Sobral da Silva, Francisco Humberto Xavier Junior, Eloisa Berbel Manaia, Gilles Ponchel, Nereide Stela Santos Magalhães, Mariane Cajubá de Britto Lira Nogueira

ACS Applied Nano Materials· Volume 8· Issue 19

Abstract

High Resolution Image Download MS PowerPoint Slide Serum proteins play an essential role in nanosystems’ stealth properties governing their distribution and targeting to specific sites. Opsonin proteins can induce nanoparticle degradation, elimination, and reduced therapeutic efficiency. The objective is to evaluate how PIBCA nanoparticles coated with fucoidan (NP-Fuc) interact with serum proteins, clarifying their behavior within the body and understanding whether this can impact the in vivo application of these nanoparticles. Static and dynamic interaction studies were carried out with bovine serum albumin (BSA), fetal bovine serum (FBS), and human serum using nanosight, absorption, and fluorescence spectroscopy. Scanning electron microscopy, infrared spectroscopy, and hydrogen nuclear magnetic resonance studies were conducted. Static and dynamic studies showed interaction of NP-Fuc with BSA, evidenced by the increase in nanoparticle size (from 349.5 ± 4.34 nm to 2 μm). Additionally, nanosight analysis also showed the interaction between BSA and NP-Fuc according to the refringence and the hydrodynamic radius (cloud effect) around the nanoparticles. The adsorption technique showed the interaction due to changes in BSA’s absorption and fluorescence profiles. Infrared and 1 H NMR spectra showed the presence of BSA in the NP-Fuc-BSA nanoparticles, indicating the protein binding to nanoparticles. Considering the results, NP-Fuc interacts with BSA to form an NP-Fuc-BSA complex. Further studies are important to optimize the size of NP-Fuc-BSA as a promising nanocarrier for drug release.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Protein Interaction Studies and Fluorescence Analysis · Proteins in Food Systems · Surfactants and Colloidal Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto Keizo-Asami (iLIKA)

Universidade Federal de Pernambuco (UFPE)

Laboratório de Nanotecnologia, Biotecnologia e Cultura de Células, Centro Acadêmico de Vitória

Universidade Federal de Pernambuco (CAV/UFPE)

Laboratório de Química e Inovação Terapêutica (LQIT)

Universidade de Pernambuco (UPE)

Laboratório de Análise Fitoquímica de Plantas Medicinais II, Departamento de Química Orgânica e Inorgânica

Universidade Federal do Ceará

Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos (PPGPNSB)

Universidade Federal da Paraíba (UFPB), Campus Universitário I, Castelo Branco III. Cidade Universitária

Instituto de Pesquisa em Fármacos e Medicamentos (IPeFarm/UFPB)

Campus Universitário I, Castelo Branco III. Cidade Universitária

Departamento de Ciências Farmacêuticas, Laboratório de Biotecnologia Farmacêutica (BioTecFarm/UFPB)

Faculté de Pharmacie Institut Galien Paris-Saclay - UMR-CNRS 8612

Université Paris

Funding

Funda??o de Amparo ? Ci?ncia e Tecnologia do Estado de Pernambuco · Universidade Federal de Pernambuco · Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico · Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior · Aux?lio Pesquisador

References (67)

Show source-provided references
1. 10.1186/1477-3155-11-2610.1186/1477-3155-11-26 ↗
2. 10.1016/j.jconrel.2020.07.00710.1016/j.jconrel.2020.07.007 ↗
3. 10.3390/molecules2516376010.3390/molecules25163760 ↗
4. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
5. 10.1021/acsnano.0c0400610.1021/acsnano.0c04006 ↗
6. 10.1016/j.ajps.2020.03.00310.1016/j.ajps.2020.03.003 ↗
7. 10.1016/j.ijpharm.2017.06.05210.1016/j.ijpharm.2017.06.052 ↗
8. 10.1016/j.jddst.2021.10269810.1016/j.jddst.2021.102698 ↗
9. 10.1016/j.ejpb.2011.02.01310.1016/j.ejpb.2011.02.013 ↗
10. 10.1007/s11095-022-03202-410.1007/s11095-022-03202-4 ↗
11. 10.1016/j.colsurfa.2017.02.05510.1016/j.colsurfa.2017.02.055 ↗
12. 10.1016/j.jddst.2019.10119410.1016/j.jddst.2019.101194 ↗
13. 10.1007/s13346-023-01329-410.1007/s13346-023-01329-4 ↗
14. 10.1016/j.carbpol.2025.12346810.1016/j.carbpol.2025.123468 ↗
15. 10.3390/md1703018310.3390/md17030183 ↗
16. 10.1038/s41598-024-82687-y10.1038/s41598-024-82687-y ↗
17. 10.1016/j.ijbiomac.2022.07.06810.1016/j.ijbiomac.2022.07.068 ↗
18. 10.1007/s11802-014-2260-y10.1007/s11802-014-2260-y ↗
19. 10.3390/md1404007910.3390/md14040079 ↗
20. 10.1016/j.ijbiomac.2017.03.18210.1016/j.ijbiomac.2017.03.182 ↗
21. 10.1155/2013/37425210.1155/2013/374252 ↗
22. 10.3390/nano910136510.3390/nano9101365 ↗
23. 10.1016/j.apsb.2021.03.03310.1016/j.apsb.2021.03.033 ↗
24. 10.1038/s41392-024-01889-y10.1038/s41392-024-01889-y ↗
25. 10.1016/j.addr.2009.03.00910.1016/j.addr.2009.03.009 ↗
26. 10.1016/j.jsps.2017.10.01210.1016/j.jsps.2017.10.012 ↗
27. 10.3390/nano1011225010.3390/nano10112250 ↗
28. 10.1016/j.ijpharm.2023.12306310.1016/j.ijpharm.2023.123063 ↗
29. 10.1007/s00044-021-02748-z10.1007/s00044-021-02748-z ↗
30. 10.1016/j.ijbiomac.2021.09.10910.1016/j.ijbiomac.2021.09.109 ↗
31. 10.1016/j.bmc.2018.10.03810.1016/j.bmc.2018.10.038 ↗
32. 10.1016/j.molliq.2018.10.12910.1016/j.molliq.2018.10.129 ↗
33. 10.1021/acsami.5b0528710.1021/acsami.5b05287 ↗
34. 10.1016/j.carbpol.2017.08.07010.1016/j.carbpol.2017.08.070 ↗
35. 10.1166/jbn.2021.313910.1166/jbn.2021.3139 ↗
36. 10.1016/0031-9422(95)00397-P10.1016/0031-9422(95)00397-P ↗
37. 10.1016/j.bbamem.2015.11.01210.1016/j.bbamem.2015.11.012 ↗
38. 10.1016/j.pdpdt.2022.10286910.1016/j.pdpdt.2022.102869 ↗
39. 10.3390/ijms24151222810.3390/ijms241512228 ↗
40. 10.1016/0022-2836(74)90031-X10.1016/0022-2836(74)90031-X ↗
41. Lakowicz J. R. · 200610.1007/978-0-387-46312-4 ↗
42. 10.3389/fphys.2014.0029910.3389/fphys.2014.00299 ↗
43. 10.1038/s41598-018-19610-910.1038/s41598-018-19610-9 ↗
44. 10.1039/C6RA25264H10.1039/C6RA25264H ↗
45. 10.1016/j.ejpb.2018.06.01410.1016/j.ejpb.2018.06.014 ↗
46. 10.3390/pharmaceutics1107029710.3390/pharmaceutics11070297 ↗
47. 10.1016/j.foodhyd.2014.10.01110.1016/j.foodhyd.2014.10.011 ↗
48. 10.1007/s11051-024-06031-110.1007/s11051-024-06031-1 ↗
49. 10.1186/s12951-023-02134-410.1186/s12951-023-02134-4 ↗
50. 10.3390/nano1204068210.3390/nano12040682 ↗
51. 10.1016/j.biomaterials.2018.07.02410.1016/j.biomaterials.2018.07.024 ↗
52. 10.3390/molecules2520470310.3390/molecules25204703 ↗
53. 10.1371/journal.pone.008631710.1371/journal.pone.0086317 ↗
54. 10.1016/j.molstruc.2009.06.03210.1016/j.molstruc.2009.06.032 ↗
55. 10.1016/j.jphotobiol.2016.06.02510.1016/j.jphotobiol.2016.06.025 ↗
56. 10.1042/EBC2016009410.1042/EBC20160094 ↗
57. 10.3390/encyclopedia101000910.3390/encyclopedia1010009 ↗
58. 10.1021/jf048693g10.1021/jf048693g ↗
59. Gobalakrishnan S. · ICCICCT · 2014 · 1172
60. 10.1155/2010/64154510.1155/2010/641545 ↗
61. 10.1021/acsomega.0c0491510.1021/acsomega.0c04915 ↗
62. 10.3390/molecules2720695910.3390/molecules27206959 ↗
63. 10.1007/s00775-012-0951-710.1007/s00775-012-0951-7 ↗
64. 2022
65. 10.1016/j.carbpol.2016.06.11210.1016/j.carbpol.2016.06.112 ↗
66. 10.1021/acsabm.8b0043610.1021/acsabm.8b00436 ↗
67. 10.3390/molecules2615446710.3390/molecules26154467 ↗